chloroquine has been researched along with Mucinoses in 2 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Mucinoses: Mucoid states characterized by the elevated deposition and accumulation of mucin (mucopolysaccharides) in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides (GLYCOSAMINOGLYCANS) in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reticular erythematous mucinosis (REM) is an uncommon disease, the nosology and specific characteristics of which are controversial because most reports deal with single cases or small series." | 1.39 | Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases. ( Cinotti, E; Cozzani, E; Ghigliotti, G; Kanitakis, J; Merlo, V; Parodi, A; Riva, S; Rongioletti, F, 2013) |
| "Reticular erythematous mucinosis (REM syndrome) is a rare cutaneous disease that predominantly affects the chest and upper back area of middle-aged women." | 1.37 | Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis: a case series of 11 patients. ( Altmeyer, P; Gambichler, T; Kreuter, A; Scola, N; Tigges, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rongioletti, F | 1 |
| Merlo, V | 1 |
| Riva, S | 1 |
| Cozzani, E | 1 |
| Cinotti, E | 1 |
| Ghigliotti, G | 1 |
| Parodi, A | 1 |
| Kanitakis, J | 1 |
| Kreuter, A | 1 |
| Scola, N | 1 |
| Tigges, C | 1 |
| Altmeyer, P | 1 |
| Gambichler, T | 1 |
2 other studies available for chloroquine and Mucinoses
| Article | Year |
|---|---|
Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Antinucl | 2013 |
Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis: a case series of 11 patients.
Topics: Adult; Antimalarials; Chloroquine; Comorbidity; Erythema; Female; Humans; Male; Middle Aged; Mucinos | 2011 |